<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04582227</url>
  </required_header>
  <id_info>
    <org_study_id>MD-202-2020</org_study_id>
    <nct_id>NCT04582227</nct_id>
  </id_info>
  <brief_title>Using Ambu Aura-i Laryngeal Mask Airway in Cranial Surgery</brief_title>
  <official_title>The Effect of Using Ambu Aura-i Laryngeal Mask Airway Versus Endotracheal Tube on Emergence Hypertension in Supratentorial Cranial Surgery: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the investigators hypothesize that Ambu aura-i LMA can be used safely in patients undergoing&#xD;
      craniotomies and are effective in reducing the incidence of emergence hypertension.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators want to assess the safety of using SGA devices in cranial&#xD;
      surgery and comparing the effect of these devices with ETT regarding hemodynamics stability&#xD;
      throughout the procedure and intracranial tension.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 30, 2020</start_date>
  <completion_date type="Anticipated">December 22, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 10, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Days</target_duration>
  <primary_outcome>
    <measure>Measure Mean blood pressure</measure>
    <time_frame>UP TO 1 HOURE</time_frame>
    <description>incidence of emergence hypertension</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure Mean Heart rate</measure>
    <time_frame>UP TO 1 HOURE</time_frame>
    <description>incidence of tachycardia or bradycardia with emergence.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>successful placement of the airway device</measure>
    <time_frame>UP TO 1 HOURE</time_frame>
    <description>Number of attempts needed for successful placement of the airway device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of postoperative complication</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>incidence of postoperative sore throat , hoarseness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>amount of fentanyl</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>by microgram</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Hypertension, Malignant</condition>
  <condition>Airway Management</condition>
  <arm_group>
    <arm_group_label>The ETT group</arm_group_label>
    <description>Oral endotracheal intubation via direct laryngoscopy will be performed. The ETT cuff will be inflated to 25 cmH2O using a manometer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The LMA group</arm_group_label>
    <description>The Ambu aura-i LMA size will be chosen and inserted using the recommended single-handed rotational technique. Subsequently, a manometer was used to inflate the cuff to 60 cm H2O.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ambu aura-i LMA</intervention_name>
    <description>The ETT or the LMA will be inserted with the patient's head position is aided either by pins or head rest, and either the head will be in neutral position or tilted as long as the airway device is successfully placed.</description>
    <arm_group_label>The LMA group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients aged from 18 to 60 years presented with brain lesions undergoing craniotomies&#xD;
        under general anaesthesia in supine position.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Study will be conducted on patients undergoing craniotomies under general anaesthesia&#xD;
             in supine position.&#xD;
&#xD;
          2. Aged 18 to 60 years.&#xD;
&#xD;
          3. ASA 1 or 2.&#xD;
&#xD;
          4. GCS ≥ 13.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who are known hypertensive, history of cardiac diseases or chest diseases&#xD;
&#xD;
          2. Patients with risk of aspiration (Obesity with BMI ≥ 40, hiatal hernia, esophageal&#xD;
             cancer and previous esophageal surgery).&#xD;
&#xD;
          3. Risk of difficult intubation&#xD;
&#xD;
          4. Extensive intracranial tumours that may affect recovery of patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr s wahdan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cairo university</name>
      <address>
        <city>Cairo</city>
        <zip>11451</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 3, 2020</study_first_submitted>
  <study_first_submitted_qc>October 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>December 18, 2020</last_update_submitted>
  <last_update_submitted_qc>December 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Amr Samir Wahdan</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia, Pain management and Surgical ICU</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>airway</keyword>
  <keyword>Laryngeal Mask Airway</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Malignant</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

